LEO Pharma has applied to the EMA to expand the label for Anzupgo (delgocitinib) cream to include adolescents.
China’s focus on first or best-in-class oncology drugs and innovative R&D will help it to secure further licensing deals in ...
US-based private investment company SK Capital Partners’ affiliate is to invest in Swixx BioPharma to support its growth and ...
Akeega’s is now FDA indicated for mCSPC and mCRPC, widening the drug’s future market potential across the prostate cancer ...
The FDA has delayed tolebrutinib’s review date again, as Sanofi also posted a Phase III failure for the MS candidate.
The US Food and Drug Administration (FDA) has granted approval for Acadia Pharmaceuticals’ Daybue Stix (trofinetide).
Sobi has signed an agreement for the acquisition of US-based biotechnology company Arthrosi Therapeutics for $950m.
Pharmaceutical packaging has always been defined by innovation, barrier protection, sterility assurance, and tamper-evident seals.
The framework has had a lukewarm reaction, with trade association EFPIA saying the policies are “not strong enough”.
Propelled by a flurry of dealmaking late in the year, 2025 M&A ended on a strong note, with high activity expected to ...
China’s National Medical Products Administration (NMPA) has granted approval for Sanofi’s rare haematologic disease ...
Zealand Pharma and OTR Therapeutics are to collaborate to discover and develop therapies for several targets in metabolic diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback